Twitter Beğeni Hilesi

1/ ⏰ for #EBGI Tweetorial🧵w/ Daryl Ramai, MD, MPH, MSc. “When to Discontinue Colon Polyp Surveillance in Older Adults?” 📜 shorturl.at/CJd5g 🎧 shorturl.at/EWstZ 📰 shorturl.at/XQJ6s #GITwitter

In the last eight years, I was honored to help many endoscopists to start their ESD practice. One of the observations I noted is that endoscopists gain sufficient ESD skills and perform around 20 to 30 cases before they start scheudling the procedure intermittently and

1/ ⏰ for #EBGI Tweetorial🧵w/ Natalie Wilson, MD! “Stemming the Tide: Is Long-Acting Octreotide Injection Better Than Standard of Care for Angiodysplasia-Related GI Bleeding?” 📜Summary bit.ly/3LDCtSH 🎧Podcast bit.ly/3Yf89FF 📰Article bit.ly/3ydmuYu

1/ ⏰ for #EBGI Tweetorial🧵w/ Fnu Vikash, MD & Sean-Patrick Prince, MBBS, MPH! “Tirzepatide Produces NASH Resolution and Decreases Fibrosis: Results from the SYNERGY-NASH Trial” 📜Summary: bit.ly/3yq9zTf 🎧 bit.ly/4cwtmyt 📰 bit.ly/46zUsDm #GITwitter

1/ ⏰ for #EBGITweetorial🧵w/ Mythili Menon Pathiyil(she/her)! “Multi-Target Stool RNA Test for CRC Screening: When Should You Use It?” 📜Summary bit.ly/3ywKTs9 🎧 Podcast bit.ly/4cfYSjR 📰Article bit.ly/4dCGNxy #GITwitter

1/ ⏰ for #EBGI Tweetorial🧵 w/Benjamin Clement, MD!​ “Can IV Metoclopramide Improve Endoscopic Visualization for Patients with Active Upper Gastrointestinal Bleeding?”​ 📜 Summary: shorturl.at/zkA6j​ 🎧 shorturl.at/g3ua1​ 📰 shorturl.at/FegCy​ #GITwitter

1/ ⏰ for #EBGI Tweetorial🧵w/ Aimen Farooq!​ “Risankizumab Is Superior to Ustekinumab for Induction and Maintenance of Crohn’s Disease: The SEQUENCE Trial” 📰 bit.ly/4cF6tbR 🎧 bit.ly/4dDqL6T 📜 bit.ly/3MlAGCf

🌟amazing tweetorial by #REACHIBD member Aimen Farooq!

1/⏰ for #EBGI Tweetorial🧵w/ Peter Bhandari, MD Long-term efficacy and safety of Ustekinumab for UC: 4 year data from the UNIFI Long-term Maintenance Study From Rahul S. Dalal, MD, MPH👇 📜 Summary shorturl.at/W7pEO 🎧 shorturl.at/bRqeL 📰 shorturl.at/Ar4zo #GITwitter